Related Experiment Videos
Nitroglycerin lingual spray: clinical efficacy and dose-response relation.
The American Journal of Cardiology
|January 1, 1986
Summary
Nitroglycerin (GTN) lingual spray effectively prevents angina episodes, with higher doses showing greater benefits. This spray offers a promising option for managing exercise-induced angina, similar to sublingual GTN.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Exercise-induced angina pectoris is a common condition.
- Nitroglycerin is a standard treatment for angina.
Purpose of the Study:
- To evaluate the efficacy and dose-response of nitroglycerin (GTN) lingual spray.
- To compare GTN lingual spray with placebo and sublingual GTN.
Main Methods:
- Twenty patients with stable, exercise-induced angina were given varying doses of GTN lingual spray (0.2, 0.4, 0.8 mg).
- Hemodynamic effects and exercise tolerance were measured.
- Comparisons were made with placebo and 0.4 mg sublingual GTN.
Main Results:
- GTN lingual spray demonstrated a dose-response relationship for heart rate.
- Exercise duration until angina onset and moderate angina was prolonged by GTN spray in a dose-dependent manner.
- GTN lingual spray (0.4 and 0.8 mg) showed effects comparable to 0.4 mg sublingual GTN.
Conclusions:
- Nitroglycerin lingual spray is effective for angina prophylaxis and treatment.
- Doses of 0.4 or 0.8 mg of GTN lingual spray appear most effective.
- GTN lingual spray offers a viable alternative to sublingual nitroglycerin for angina management.